• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-环糊精对氨苄西林在水溶液中聚合的抑制作用。

Inhibitory effect of beta-cyclodextrin on ampicillin polymerization in aqueous solution.

作者信息

Aki H, Yamamoto K, Sawai N, Yamamoto M

机构信息

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.

出版信息

Drug Des Deliv. 1990 Dec;7(1):59-63.

PMID:2096835
Abstract

Ampicillin polymerizes in aqueous solution to produce antigenic polymers; the polymers were separated by anion-exchange chromatography and shown to consist of a dimer, trimer, tetramer and pentamer of ampicillin by the masses found in fast atom bombardment mass spectroscopy. The presence of an intact beta-lactam ring in each of the polymers was revealed by the characteristic positive Cotton effect near 230 nm in their circular dichroism spectra. beta-Cyclodextrin was found to inhibit this polymerization by complex formation involving equimolar quantities of the constituents. Formation of this complex was complete in 10% aqueous solution within 6 hr at 24 degrees C. The positive Cotton effect arising from the beta-lactam ring decreased as the degree of polymerization increased, but was unchanged by the complex formation with beta-cyclodextrin.

摘要

氨苄西林在水溶液中聚合产生抗原性聚合物;这些聚合物通过阴离子交换色谱法分离,并通过快速原子轰击质谱法测定的质量表明由氨苄西林的二聚体、三聚体、四聚体和五聚体组成。它们的圆二色光谱在230nm附近有特征性的正科顿效应,表明每种聚合物中均存在完整的β-内酰胺环。发现β-环糊精通过涉及等摩尔量成分的复合物形成来抑制这种聚合。在24℃下,这种复合物在10%水溶液中6小时内形成完全。随着聚合度增加,β-内酰胺环产生的正科顿效应降低,但与β-环糊精形成复合物后该效应未改变。

相似文献

1
Inhibitory effect of beta-cyclodextrin on ampicillin polymerization in aqueous solution.β-环糊精对氨苄西林在水溶液中聚合的抑制作用。
Drug Des Deliv. 1990 Dec;7(1):59-63.
2
Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.β-环糊精与三-O-甲基-β-环糊精在水溶液中与几种药物包合作用的比较研究。
Acta Pharm Suec. 1984;21(6):357-66.
3
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays.芦丁/β-环糊精在完全水溶液中的相互作用:光谱研究与生物学测定
J Pharm Biomed Anal. 2005 Jan 4;36(5):1019-27. doi: 10.1016/j.jpba.2004.09.018.
4
Guest-to-host proton transfer in melatonin-beta-cyclodextrin inclusion complex by ionspray, fast atom bombardment and tandem mass spectrometry.通过离子喷雾、快原子轰击和串联质谱法研究褪黑素-β-环糊精包合物中客体到主体的质子转移
J Mass Spectrom. 2001 Nov;36(11):1189-94. doi: 10.1002/jms.226.
5
Stability of natamycin and its cyclodextrin inclusion complexes in aqueous solution.纳他霉素及其环糊精包合物在水溶液中的稳定性。
J Agric Food Chem. 2003 Nov 19;51(24):7111-4. doi: 10.1021/jf030333q.
6
Fluorometric studies on inclusion complexation of L/D-tryptophan by beta-cyclodextrin 6-O-pyridinecarboxylates.β-环糊精6-O-吡啶羧酸盐对L/D-色氨酸包合络合作用的荧光研究
Bioorg Chem. 2001 Feb;29(1):19-26. doi: 10.1006/bioo.2000.1188.
7
Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.水溶性聚合物对萘普生与天然及化学修饰β-环糊精络合的影响。
Drug Dev Ind Pharm. 2001 Oct;27(9):909-17.
8
Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability of a naphthoquinone in aqueous solutions.羟丙基-β-环糊精对萘醌在水溶液中化学稳定性的影响。
Pharmazie. 2003 Jan;58(1):32-7.
9
Chiral recognition by the copper(II) complex of 6-deoxy-6-N-(2-methylaminopyridine)-beta-cyclodextrin.6-脱氧-6-N-(2-甲基氨基吡啶)-β-环糊精铜(II)配合物的手性识别
Chirality. 1997;9(4):341-9. doi: 10.1002/(SICI)1520-636X(1997)9:4<341::AID-CHIR5>3.0.CO;2-G.
10
Structural characterization of imazalil/beta-cyclodextrin inclusion complex.抑霉唑/β-环糊精包合物的结构表征
J Agric Food Chem. 2004 Mar 24;52(6):1590-3. doi: 10.1021/jf034827z.

引用本文的文献

1
Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.环糊精与抗生素及抗菌剂形成的包合物作为药物递送系统——药学视角
Pharmaceutics. 2022 Jun 30;14(7):1389. doi: 10.3390/pharmaceutics14071389.